SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-011396
Filing Date
2022-03-22
Accepted
2022-03-22 17:15:39
Documents
15
Period of Report
2022-05-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A gern-def14a_20220510.htm DEF 14A 3531422
2 GRAPHIC gjslqj3neoxi000002.jpg GRAPHIC 11708
3 GRAPHIC gjslqj3neoxi000004.jpg GRAPHIC 8847
4 GRAPHIC gjslqj3neoxi000012.jpg GRAPHIC 3208
5 GRAPHIC gjslqj3neoxi000009.jpg GRAPHIC 1060
6 GRAPHIC gjslqj3neoxi000003.jpg GRAPHIC 3208
7 GRAPHIC gjslqj3neoxi000001.jpg GRAPHIC 3208
8 GRAPHIC gjslqj3neoxi000005.jpg GRAPHIC 1060
9 GRAPHIC gjslqj3neoxi000013.jpg GRAPHIC 1001
10 GRAPHIC gjslqj3neoxi000014.jpg GRAPHIC 3727
11 GRAPHIC gjslqj3neoxi000011.jpg GRAPHIC 8847
12 GRAPHIC gjslqj3neoxi000006.jpg GRAPHIC 1060
13 GRAPHIC gjslqj3neoxi000008.jpg GRAPHIC 1060
14 GRAPHIC gjslqj3neoxi000007.jpg GRAPHIC 1060
15 GRAPHIC gjslqj3neoxi000010.jpg GRAPHIC 1060
  Complete submission text file 0001564590-22-011396.txt   3603788
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20859 | Film No.: 22760669
SIC: 2834 Pharmaceutical Preparations